Clinical trial of COVID-19 vaccine resuming at KU Wichita Center for Clinical Research

The University of Kansas School of Medicine-Wichita Center for Clinical Research has resumed leading the local effort of a nationwide clinical trial brought through the COVID-19 Prevention Network testing the COVID-19 vaccine AZD1222, developed by Oxford University and purchased by AstraZeneca.